Albert Tsai

As China’s pharma industry continues to evolve and mature, it is hoped overseas expansion and greater innovation will be exported to serve the interests of patients.

Chinese biotech companies are emerging as serious competitors in the global market as the country's drug development landscape claims industry attention once more.